These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25385367)

  • 1. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
    Choi EY; Lim JH; Neuwirth A; Economopoulou M; Chatzigeorgiou A; Chung KJ; Bittner S; Lee SH; Langer H; Samus M; Kim H; Cho GS; Ziemssen T; Bdeir K; Chavakis E; Koh JY; Boon L; Hosur K; Bornstein SR; Meuth SG; Hajishengallis G; Chavakis T
    Mol Psychiatry; 2015 Jul; 20(7):880-888. PubMed ID: 25385367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
    Li H; Park D; Abdul-Muneer PM; Xu B; Wang H; Xing B; Wu D; Li S
    Neuroscience; 2013 Dec; 253():89-99. PubMed ID: 24012746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
    Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
    Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
    Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
    J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
    Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
    J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model.
    Yin JX; Tu JL; Lin HJ; Shi FD; Liu RL; Zhao CB; Coons SW; Kuniyoshi S; Shi J
    PLoS One; 2010 Aug; 5(8):e12400. PubMed ID: 20811645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
    Front Immunol; 2020; 11():575451. PubMed ID: 33329540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss.
    Eskan MA; Jotwani R; Abe T; Chmelar J; Lim JH; Liang S; Ciero PA; Krauss JL; Li F; Rauner M; Hofbauer LC; Choi EY; Chung KJ; Hashim A; Curtis MA; Chavakis T; Hajishengallis G
    Nat Immunol; 2012 Mar; 13(5):465-73. PubMed ID: 22447028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
    Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
    J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair.
    Mohajeri M; Sadeghizadeh M; Najafi F; Javan M
    Neuropharmacology; 2015 Dec; 99():156-67. PubMed ID: 26211978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.